RxDoctor Payments Data

Glenn Fussell, MD

Family Medicine · Columbus, GANPI 1861509184

Payments from drug & device makers

$2,422in general payments, 2019–2025

Across 144 payments — averaging $16.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$592
  • AbbVie$493
  • Lilly USA, LLC$204
  • Abbott$200
  • Novartis$160
  • Esperion Therapeutics, Inc.$151
  • plus $622 from 16 others

What the payments were for

  • Food & beverage$2,32296%
  • Education$1004%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,422 in reported general payments places this provider in the 70th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$190,092
Medicare patients
304
Services billed
2,283

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide136$190,681
JardianceEmpagliflozin107$107,819
JanuviaSitagliptin Phosphate48$71,545
EliquisApixaban46$54,004
FarxigaDapagliflozin Propanediol39$47,058
TriumeqAbacavir/Dolutegravir/Lamivudi12$46,345
EntrestoSacubitril/Valsartan30$30,661
MounjaroTirzepatide17$27,650
TrulicityDulaglutide17$27,315
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$25,503
LinzessLinaclotide19$22,970
MyrbetriqMirabegron18$16,501
TradjentaLinagliptin11$16,096
SymbicortBudesonide/Formoterol Fumarate36$14,535
Tresiba Flextouch U-100Insulin Degludec12$12,348

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$592$190,681136 claims
Boehringer IngelheimJardiance, Tradjenta$30$123,915118 claims
MerckJanuvia$37$71,54548 claims
AstraZenecaFarxiga, Symbicort$18$61,59375 claims
Lilly USA, LLCMounjaro, Trulicity$204$54,96534 claims
PfizerEliquis$56$54,00446 claims
NovartisEntresto$160$30,66130 claims
AbbVieLinzess$493$22,97019 claims
Astellas Pharma US IncMyrbetriq$132$16,50118 claims
Esperion Therapeutics, Inc.Nexlizet$151$7,34514 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Columbus

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →